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Introduction
Hypothesis
We hypothesized that excess reactive oxidative
species (ROS) alter the tight balance between
osteoclast and osteoblast activities, leading to
accelerated skeletal remodeling and culminating in
bone loss, resembling aging.
To test this, we first used an intrinsic approach
with a transgenic mouse model. 1) We used the
mCAT mouse model; these transgenic mice over-
express the human catalase gene targeted to
mitochondria (Schriner at al.), the major organelle
contributing free radicals. Catalase is an anti-
oxidant that converts a major reactive species,
hydrogen peroxide (H202), into water and oxygen.
This animal model was selected as it displays
extended lifespan, reduced cardiovascular disease
and reduced central nervous system
radiosensitivity, consistent with elevated anti-
oxidant activity conferred by the transgene.
Secondly we used an extrinsic approach by
applying a treatment we know will incur bone loss
and oxidative damage. 2) The treatment consists
of hindlimb-unloading and total Body irradiation
(TBI) combined. We reasoned that mice
overexpressing catalase in mitochondria of
osteoblast and osteoclast lineage cells would be
protected from the bone loss caused by treatment
causing bone loss, in this case simulated
spaceflight.
Background
Catalase and Reactive Oxygen Species
When detrimental reactive oxygen species (ROS) are
formed in the cell, catalase converts H2O2 to water
and oxygen.
Bone remodeling
A balance between bone forming cells (osteoblasts)
and bone resorbing cells (osteoclasts) in skeletal
tissue is essential to maintain bone health.
Summary & Conclusions
• mCAT mice over-expressed the transgene in bone tissue and bone cells ex vivo (marrow-derived marrow osteoblasts and osteoclast precursors); and mCAT 
mice also showed elevated catalase activity compared to WT in these same tissue and cells.
• Treatment (HU and IR) increased lipid peroxidation (MDA, HNE) in bone tissue of WT, but not mCAT mice. 
★ Therefore, mCAT mice are useful models to analyse the influence of quenching mitochondrial ROS on bone phenotype.
• mCAT mice (untreated) had lower cancellous percent bone volume, trabecular number, and structural integrity (SMI) compared to WT mice (untreated); and 
reduced cortical area.
★ Endogenous H2O2 generation is likely important for normal bone remodeling and skeletal integrity.
•Treatment (HU and IR) of both WT and mCAT mice caused loss of cancellous tissue.
•In contrast, treatment of mCAT mice showed an unexpected increase in cortical bone area and other cortical parameters after treatment. 
★ Overexpression of catalase in mitochondria disrupts typical skeletal responses to the challenges of simulated spaceflight (treatment with 
HU and IR). 
• Catalase overexpression in mCAT mice increased both ex vivo osteoblasts colony expansion, but not osteoclast differentiation, compared to WT mice. 
• Statistical analysis revealed strong correlations between catalase expression in both bone tissue and ex vivo osteoblast and increased osteoblast colony 
formation. In addition, we observed a negative correlation between catalase activity, oxidative damage in bone and skeletal structure.
★ Oxidative defence pathways in both osteoblast and osteoclast-lineage cells are likely important for protection against skeletal challenges 
such as those imposed by irradiation and musculoskeletal disuse.
• mCAT mice expressed mRNA for the human catalase gene in both skeletal tissue (A) and
marrow-derived cultures of osteoblast (B) and osteoclast precursors (C). Hearts served as
positive controls.
• mCAT mice displayed 3-4-fold greater catalase enzymatic activity compared to WT mice in bone
extracts (D), osteoblastic cultures (E) and osteoclast precursors (F), thereby confirming that
transgene was enzymatically active.
• Colony numbers during osteoblastogenesis: the number of colonies 
from marrow cells of mCAT mice increased more rapidly during growth 
than those from WT mice (A). Extent of mineralization at terminal 
differentiation was unaffected by genotype (B). 
• No significant differences due to genotype or treatment were observed 
in ex vivo osteoclast formation (C), and activity (D).
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Methods
Mice were bred to obtain groups of mCAT
hemizygotes and wildtype (WT) littermates.
Fourteen week old male mice of each genotype
were separated into two groups, controls
(untreated) or treated to simulate some aspects of
spaceflight (n=7-9/group). Treatment consisted of
hindlimb unloading (which simulates
weightlessness) followed three days later by
exposure to total body irradiation with 137Cs 2Gy,
0.8Gy/min. After two weeks, tissues were
harvested. Some bones were flushed to collect
bone marrow for ex vivo cell culture to assess
osteoblastogenesis and osteoclastogenesis. Other
tibiae and femora were recovered to analyze gene
expression, catalase activity and microarchitecture
by 3D micro-computed tomography. Data were
analyzed by one way ANOVA to compare all the
groups with a Bonferroni correction to allow three
comparisons (WT untreated vs mCAT untreated,
WT untreated vs treated, and mCAT untreated vs
treated) and p<0.017 was used as significance level
using post-hoc Student t-test. Data are
represented as mean +/- SEM.
• Oxidative damage was assessed in mineralized tissue
using malondialdehyde (A, MDA) levels and 4-
Hyroxynonenal (B, HNE) normalized to total protein
content.
• Untreated Control WT and mCAT mice displayed no
genotype-dependent differences in oxidative damage
whereas treatment increased MDA and HNE content in
skeletal tissue of WT but not mCAT mice.
• Negative correlation between oxidative damage and catalase activity in bone (A),
which validates that this transgenic mice model is suitable for studying oxidative
damage in bone-related studies.
• Negative correlation between oxidative damage and cancellous BV/TV (B), potentially
confirming our hypothesis of the role of oxidative damage and bone loss.
• Positive correlation between catalase activity in bone tissue (B) and catalase activity
in ex vivo osteoblasts (C) with osteoblasts colony growth, confirming the observation
that mCAT mice have increased ex vivo osteoblast colony formation (Fig 4).
Bone loss occurs due to age, radiation and 
microgravity and is characterized by alterations in the 
balance between bone formation and resorption. The 
production of Reactive Oxygen Species (ROS) and/or 
Reactive Nitrogen Species  (RNS) plays a signalling 
role in responses to various intrinsic stimuli (such as 
hormones and mechanical loading) but when 
produced in excess after exposure to extrinsic stimuli 
(such as ionizing radiation) can lead to oxidative 
damage and tissue dysfunction. 
1. Genotype effects: comparing Untreated mice (WT to mCAT)
• Cancellous: mCAT mice showed differences from WT mice in percent bone volume (BV/TV, A, -16%), trabecular numbers (Tb.N, D, -18%), and structural model 
index (SMI, E, +13%).
• Cortical bone: mCAT mice differed from WT in cortical area only (Ct.Ar, B, -7 %) but not other parameters.  
2. Treatment effects
• Both the WT and mCAT mice showed significant bone loss after treatment in the cancellous bone.
• Interestingly, the mCAT mice, but not the WT mice, displayed radial growth in cortical bone after treatment, as seen in Tissue Area (Tt.Ar, A), Cortical Area 
(Ct.Ar, B), endocortical perimeter (Ec.Pm, C) and polar moment of inertia (MOI, F).
Figure 1: mCAT transgenic mice express the human catalase gene and display increased 
catalase activity. 
Figure 2: mCAT mice display reduced oxidative damage 
in skeletal tissue after treatment compared to WT
Figure 3: Skeletal microarchitecture Cancellous and Cortical
Figure 4: Ex Vivo Osteoblastogenesis and Osteoclastogenesis Figure 5: Correlation analysis
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